Weiwei Zhang
6 Papers
Weiwei Zhang is an academic researcher. The author has contributed to research in topics: Internal medicine & Hematopoietic stem cell transplantation. The author has co-authored 1 publications.
Chat about Author
Papers
Double Donor Lymphocytes Infusion Reduced the Rejection in Tαβ Cell Depleted Hematopoietic Stem Cell Transplantation from Haploidentical Donors for Thalassemia Patients
Jianyu Liao,Chaoke Bu,Lan He,Yuelin He,Jujian He,Dan Chen,Bo Lyu,Weiwei Zhang,Haoran Tang,Xinrui Liu,Chunfu Li +10 more
TL;DR: Wang et al. as mentioned in this paper showed that double donor lymphocyte infusion (DLI) reduced the rejection in haplo-TDH for thalassemia major (TM) patients.
1
A Novel Protocol Improves Engraftment in Tαβ + Cell Depleted Haplo-HSCT for Patients with Thalassemia Major
Jianyu Liao,Chaoke Bu,Lan He,Yuelin He,Jujian He,Dan Chen,Bo Lyu,Weiwei Zhang,Haoran Tang,Xinrui Liu,Chunfu Li +10 more
TL;DR: A prospective/retrospective single-center clinical study on the engraftment in thalassemia major patients diagnosed with TDH at the BMT-center, Taixin Hospital, finds that out of 137 patients, 133 achieved successful engraftMENT (97.1%) with median engraftments times of 16 days.
P1322: effects of donor-specific anti-hla antibodies (dsa) for primary graft failure of haploidentical hematopoietic stem cell transplantation in thalassemia major
Jianyu Liao,Chaoke Pu,Lan He,Jujian He,Weiwei Zhang,Yuqian Xia,Yuelin He,Chunfu Li +7 more
TL;DR: This study investigates the effects of donor-specific anti-HLA antibodies on primary graft failure in thalassemia major patients undergoing haploidentical hematopoietic stem cell transplantation, finding DSA to be a significant barrier to successful engraftment, particularly at high median fluorescence intensity levels.
Treatment of Mixed Chimerism After Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major
Shimin Liang,Xiaoting Liu,Yuqian Xia,Jujian He,Weiwei Zhang,Chaoke Pu,Lan He,Chunfu Li +7 more
TL;DR: Treatment of mixed chimerism after hematopoietic stem cell transplantation in patients with thalassemia major is achieved by immunosuppression withdrawal (ISW) in MC1 and donor lymphocyte infusion (DLI) in late-stage MC2.
Different Sources of Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: Relationship between Immune Reconstitution, Graft-Versus-Host Disease, and Viral Infections
Jianyu Liao,Chaoke Bu,Lan He,Huaying Liu,Zhiyong Peng,Weiwei Zhang,Haoran Tang,Jing Wang,Zimao Lu,Yanfeng Zhou,Yuqian Xia,Yuelin He,Chunfu Li +12 more
TL;DR: To compare the relationship among immune reconstitution, graft-versus-host disease (GVHD), and viral infections in three kinds of hematopoietic stem cell transplantation using different host sources for thalassemia major patients, a total of 191 TM patients were included in this study.